Visalytics
Visalytics
approved EB-2 (NIW)

Postdoctoral Research Associate

Biomedical Science · China · 2024-02-13

Processing Time
6 days
Decision Date
2024-02-13
Location
Rhode Island
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner focuses on the identification of new cellular genes and pathways that influence virus infection dynamics. Her work aims to address critical public health issues including opioid dependency, the development of safe vaccinations against SARS-CoV-2, and the management of colorectal and pancreatic cancers.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses critical issues like opioid dependency and cancer management, which have significant implications for U.S. public health.

2 Well-positioned to Advance the Endeavor Met

The petitioner's record of 1,116 citations and 14 publications in high-impact journals demonstrates her ability to successfully lead biomedical research.

3 Waiver of Job Offer and Labor Certification Met

Given the petitioner's unique expertise and the inherent value of her research to the U.S. economy and health sector, waiving the labor certification is beneficial.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in pharmacology, 14 peer-reviewed journal articles, and 1,116 citations from scholars in 45 countries. Additionally, she conducted 40 peer-reviewed journal reviews and provided expert letters from internationally renowned scientists at elite institutions, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Original Contributions
Judging Experience

Similar Cases

Postdoctoral Researcher

Biotechnology · India

WeGreened EB-2 (NIW) approved
Massachusetts 30 days 2025-06-07
The petitioner proposes to develop and apply advanced immunological and virological methodologies to investigate viral persistence and immune response mechanisms. The work specifically focuses on chronic diseases such as HIV and Epstein-Barr Virus (EBV) to advance therapeutic strategies and vaccine development. This research aims to lower disease burdens and improve public health outcomes by addressing infectious disease control.
View Case

Research Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
Maryland 28 days 2025-08-20
The petitioner proposes to continue her research into how HIV establishes viral reservoirs that allow it to persist despite treatment. She utilizes advanced single-molecule and live-cell imaging techniques to uncover molecular mechanisms sustaining viral transcription. Her work aims to identify strategies for developing a functional cure for HIV.
View Case

Postdoctoral Researcher

Research and Development · South Korea

WeGreened EB-2 (NIW) approved
California 174 days 2022-09-29
The petitioner proposes to continue identifying lead molecules to develop novel drugs for treating cancer, autoimmune diseases, addiction, neurodegenerative diseases, and viral infections. The work specifically focuses on translesion synthesis to support the development of targeted therapeutics that circumvent drug resistance in cancer patients.
View Case

Doctor

Healthcare · Turkey

WeGreened EB-2 (NIW) approved
New York 15 days 2025-04-17
The petitioner proposes to enhance the understanding of chronic diseases, including cancer, diabetes, and cardiovascular illnesses, by exploring genetic predispositions and novel chemopreventive agents. His work focuses on improving therapeutic efficacy and reducing public health burdens through innovative, patient-focused strategies and translational immunotherapy research.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2024-02-13.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 6 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,816
Success Rate 53.6%
Sustained 2,046
Dismissed 1,674

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist